Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature
Mohd Imran, Hamdy Khamees Thabet, Saleh I. Alaqel, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 876-876
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Quercetin in the Prevention and Treatment of Coronavirus Infections: A Focus on SARS-CoV-2
Amin Gasmi, Pavan Kumar Mujawdiya, Roman Lysiuk, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1049-1049
Open Access | Times Cited: 73
Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases
Syed A. A. Rizvi, George P Einstein, Orien L. Tulp, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1442-1442
Open Access | Times Cited: 71
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
Francesco Di Pierro, Amjad Khan, Somia Iqtadar, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 36
Protective effects and mechanisms of quercetin in animal models of hyperuricemia: A systematic review and meta-analysis
Xueren Bian, Z. K. Ge, Xu-Shan Chen, et al.
Pharmacological Research (2025), pp. 107665-107665
Open Access | Times Cited: 1
Understanding chronic inflammation: couplings between cytokines, ROS, NO, Cai2+, HIF-1α, Nrf2 and autophagy
Katarzyna Michalak, Alicja Michalak
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
Mazen Almehmadi, Mamdouh Allahyani, Ahad Amer Alsaiari, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1870-1870
Open Access | Times Cited: 38
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 36
Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects
Mohd Imran, Mohammed Kanan Alshammari, Mandeep Kumar Arora, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 278-278
Open Access | Times Cited: 22
Targeting Nrf2 signaling pathway by quercetin in the prevention and treatment of neurological disorders: An overview and update on new developments
Mohammad Yasin Zamanian, Afsaneh Soltani, Zahra Khodarahmi, et al.
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 6, pp. 1050-1064
Closed Access | Times Cited: 22
Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer’s Disease
Claire Alexander, Ali Parsaee, Maryam Vasefi
Biology (2023) Vol. 12, Iss. 11, pp. 1453-1453
Open Access | Times Cited: 20
Exploring the Interplay of Food Security, Safety, and Psychological Wellness in the COVID-19 Era: Managing Strategies for Resilience and Adaptation
Fanrui Zhou, Zhengxin Ma, Ahmed K. Rashwan, et al.
Foods (2024) Vol. 13, Iss. 11, pp. 1610-1610
Open Access | Times Cited: 8
Impact of selenium nanoparticles in the regulation of inflammation
Asif Raza, Hannah Johnson, Amandeep Singh, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 732, pp. 109466-109466
Closed Access | Times Cited: 25
Selenium and COVID-19: A spotlight on the clinical trials, inventive compositions, and patent literature
Mohammed Kanan Alshammari, Waseem Fatima, Reem Ahmed Alraya, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 11, pp. 1225-1233
Open Access | Times Cited: 23
Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 10, pp. 100125-100125
Open Access | Times Cited: 14
MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature
Mohd Imran, Mandeep Kumar Arora, Anurag Chaudhary, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2793-2793
Open Access | Times Cited: 21
Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors
Nicoletta Brindani, Federico Munafò, Andrea Menichetti, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 80, pp. 117179-117179
Open Access | Times Cited: 11
Phytochemical Insights into Flavonoids in Cancer: Mechanisms, Therapeutic Potential, and the Case of Quercetin
Piero Alex Silva-Pinto, Janaína Teixeira Costa de Pontes, Brigitte Aguilar-Morón, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42682-e42682
Open Access
Role of quercetin as a promising antiviral,therapeutic and immunomodulatory mediator against dengue virus induced robust infection in in-vivoBalb/C mice model
Saikat Mukherjee, Anusri Tripathi�
European Journal of Medicinal Chemistry (2025), pp. 117536-117536
Closed Access
Inhibitory effect of food-functioned phytochemicals on dysregulated inflammatory pathways triggered by SARS-CoV-2: a mechanistic review
Ibrahim Jantan, Nor Azrina Norahmad, Yuandani Yuandani, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-26
Closed Access | Times Cited: 3
Transformation of peptides to small molecules in medicinal chemistry: Challenges and opportunities
Zeyu Han, Zekai Shen, Jiayue Pei, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4243-4265
Open Access | Times Cited: 3
3C-like proteases in SARS-CoV-2
Kenana Al Adem, Juliana C. Ferreira, Adrian J. Villanueva, et al.
Bioscience Reports (2024)
Open Access | Times Cited: 3
Photodynamic Action of Curcumin and Methylene Blue against Bacteria and SARS-CoV-2—A Review
Siukan Law, Albert Wingnang Leung, Chuanshan Xu
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 34-34
Open Access | Times Cited: 9
Comparison study of Beninese and Chinese herbal medicines in treating COVID-19
Elisabeth A. Houeze, Yi Wang, Qian Zhou, et al.
Journal of Ethnopharmacology (2023) Vol. 308, pp. 116172-116172
Open Access | Times Cited: 7
Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis
Ke Liu, Yi Zhu, X. L. Cao, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21648-e21648
Open Access | Times Cited: 7
Carbonization of quercetin into nanogels: a leap in anticoagulant development
Han‐Wei Chu, Wan-Jyun Chen, Ko-Hsin Liu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 22, pp. 5391-5404
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top